News

According to ChainCatcher, as reported by PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. has announced the implementation of a digital asset management strategy. The company plans to allocate $10 million (approximately 50% of its current cash reserves) to digital asset investments. The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. The strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yield, and risk hedging strategies. To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

On August 25, it was announced that the Ethereum Layer 2 project Ronin has launched a "Developer Revenue Sharing Program." Whether developing games, applications, or migrating projects to Ronin, developers can increase their earnings through this initiative. Specifically, the "Developer Revenue Sharing Program" will return a portion of Sky Mavis's total revenue to developers. Referrers will receive rewards when referred users perform any of the following transactions: · Minting NFTs on the Ronin Launchpad · Conducting secondary market transactions on the Ronin Marketplace · Making purchases through the Ronin Store or in-game purchases · Paying Ronin Wallet exchange fees